Personalized Medicine for Ovarian Cancer


In 2003, the Human Genome Project was completed. This thirteen-year project was supposed to revolutionize the world of medicine, and it did help scientists understand a great deal more about the human genetic condition. It also raised considerably more questions. At the time everyone thought medicine would soon be developed to treat specific people based on their genetic information.  Medicine has developed even further in the last eight years, but there are currently only a handful of medications that factor genetic information. A new genetic study of ovarian cancer may increase the ability of physicians, scientists, and pharmacists to personalize medicine even further. Continue reading “Personalized Medicine for Ovarian Cancer”